Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05840250 · ClinicalTrials.gov registry record · NA
Continuous Glucose Monitoring and Diabetes
A NA study, sponsored by Hackensack Meridian Health.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT05840250 is a NA study that was terminated before completion, run by Hackensack Meridian Health. The registered enrollment target is 10 participants.
The verdict
NCT05840250, a NA study, was terminated before completion, sponsored by Hackensack Meridian Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The study is a longitudinal single-arm prospective study design. Adult patients who are African American or Hispanic with type 2 diabetes mellitus will be recruited to participate in this study. The goal of the study is to determine if the use of a continuous glucose monitoring system will improve diabetes management in persons from health disparity background. The subjects will be closely monitored for the first 3 months as they utilize the continuous glucose monitor and engage in diabetes education classes. They will then be followed for an additional 3 months to determine if they are able to maintain the same glucose control as experienced for the initial 3 months.
Interventions
- OTHER Continuous Glucose Monitoring and Education Support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2023-05-15 |
| Est. Completion | 2024-09-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05840250
The ClinicalTrials.gov registry entry for NCT05840250 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hackensack Meridian Health, which has 90 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Continuous Glucose Monitoring and Education Support is the first listed.
NCT05840250 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05840250 about?
NCT05840250 is a clinical study titled "Continuous Glucose Monitoring and Diabetes". The study is a longitudinal single-arm prospective study design. Adult patients who are African American or Hispanic with type 2 diabetes mellitus will be recruited to participate in this study. The goal of the study is to determine if the use of a continuous glucose monitoring system will improve d...
What is the current status of trial NCT05840250?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2023-05-15. Estimated completion is 2024-09-14.
What interventions are being tested in trial NCT05840250?
The interventions under investigation include: Continuous Glucose Monitoring and Education Support (OTHER).
Who is sponsoring clinical trial NCT05840250?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.